Institute of Pharmacology, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, Shandong, 271016, China.
Taian City Central Hospital, Tai'an, Shandong, 271016, China.
Metab Brain Dis. 2023 Oct;38(7):2465-2476. doi: 10.1007/s11011-023-01242-2. Epub 2023 May 31.
Depression is among the most frequent psychiatric comorbid conditions in Alzheimer disease (AD). However, pharmacotherapy for depressive disorders in AD is still a big challenge, and the data on the efffcacy of current antidepressants used clinically for depressive symptoms in patients with AD remain inconclusive. Here we investigated the mechanism of the interactions between depression and AD, which we believe would aid in the development of pharmacological therapeutics for the comorbidity of depression and AD. Female APP/PS1/Tau triple transgenic (3×Tg-AD) mice at 24 months of age and age- and sex-matched wild-type (WT) mice were used. The shuttle-box passive avoidance test (PAT) were implemented to assess the abilities of learning and memory, and the open field test (OFT) and the tail suspension test (TST) were used to assess depression-like behavior. High-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) was used to detect the level of neurotransmitters related to depression in the hippocampus of mice. The data was identified by orthogonal projections to latent structures discriminant analysis (OPLS-DA). Most neurotransmitters exert their effects by binding to the corresponding receptor, so the expression of relative receptors in the hippocampus of mice was detected using Western blot. Compared to WT mice, 3×Tg-AD mice displayed significant cognitive impairment in the PAT and depression-like behavior in the OFT and TST. They also showed significant decreases in the levels of L-tyrosine, norepinephrine, vanillylmandelic acid, 5-hydroxytryptamine, and acetylcholine, in contrast to significant increases in 5-hydroxyindoleacetic acid, L-histidine, L-glutamine, and L-arginine in the hippocampus. Moreover, the expression of the alpha 1a adrenergic receptor (ADRA1A), serotonin 1 A receptor (5HT1A), and γ-aminobutyric acid A receptor subunit alpha-2 (GABRA2) was significantly downregulated in the hippocampus of 3×Tg-AD mice, while histamine H3 receptor (H3R) expression was significantly upregulated. In addition, the ratio of phosphorylated cAMP-response element-binding protein (pCREB) and CREB was significantly decreased in the hippocampus of 3×Tg-AD mice than WT mice. We demonstrated in the present study that aged female 3×Tg-AD mice showed depression-like behavior accompanied with cognitive dysfunction. The complex and diverse mechanism appears not only relevant to the imbalance of multiple neurotransmitter pathways, including the transmitters and receptors of the monoaminergic, GABAergic, histaminergic, and cholinergic systems, but also related to the changes in L-arginine and CREB signaling molecules.
抑郁症是阿尔茨海默病(AD)最常见的精神共病之一。然而,AD 患者抑郁障碍的药物治疗仍然是一个巨大的挑战,目前临床上用于治疗 AD 患者抑郁症状的抗抑郁药的疗效数据仍不确定。在这里,我们研究了抑郁与 AD 之间相互作用的机制,我们相信这将有助于开发治疗抑郁与 AD 共病的药理学疗法。使用 24 月龄雌性 APP/PS1/Tau 三转基因(3×Tg-AD)小鼠和年龄及性别匹配的野生型(WT)小鼠。采用穿梭箱被动回避试验(PAT)评估学习记忆能力,采用旷场试验(OFT)和悬尾试验(TST)评估抑郁样行为。采用高效液相色谱-串联质谱法(HPLC-MS/MS)检测小鼠海马与抑郁相关的神经递质水平。通过正交投影到潜在结构判别分析(OPLS-DA)对数据进行鉴定。大多数神经递质通过与相应受体结合发挥作用,因此使用 Western blot 检测小鼠海马中相对受体的表达。与 WT 小鼠相比,3×Tg-AD 小鼠在 PAT 中表现出明显的认知障碍,在 OFT 和 TST 中表现出抑郁样行为。与海马中 5-羟吲哚乙酸、组氨酸、谷氨酰胺和精氨酸显著增加相比,它们还显示 L-酪氨酸、去甲肾上腺素、香草扁桃酸、5-羟色胺和乙酰胆碱水平显著降低。此外,3×Tg-AD 小鼠海马中 α1a 肾上腺素能受体(ADRA1A)、5-羟色胺 1A 受体(5HT1A)和 γ-氨基丁酸 A 受体亚单位α-2(GABRA2)的表达明显下调,而组氨酸 H3 受体(H3R)的表达明显上调。此外,与 WT 小鼠相比,3×Tg-AD 小鼠海马中磷酸化 cAMP 反应元件结合蛋白(pCREB)与 CREB 的比值明显降低。本研究表明,老年雌性 3×Tg-AD 小鼠表现出抑郁样行为伴认知功能障碍。这种复杂多样的机制不仅与单胺能、GABA 能、组胺能和胆碱能系统的多种神经递质途径的失衡有关,还与 L-精氨酸和 CREB 信号分子的变化有关。